Stock · Pharmaceuticals
Johnson & Johnson real return vs inflation and money printing JNJ
Johnson & Johnson. Healthcare group making prescription medicines and medical devices.
Key numbers
- 1-month change
- -6.0%
- Volatility (30-day, annualised)
- 23.8%
Johnson & Johnson real return after inflation and money printing
In dollars and pounds, before and after inflation, since Jan 1985.
+162%Johnson & Johnson after US inflation since 20105.9% a year
Up 306% in dollars since 2010. After US inflation, up 162%. Against money printing, up 48.0%.
In pounds, up 396%, or up 204% after UK inflation.
- $ nominal
- +306%8.7% a year
- £ nominal
- +396%10.0% a year
- Real $ (US CPI)
- +162%5.9% a year
- Real £ (UK CPI)
- +204%6.8% a year
- vs US M2
- +48.0%2.4% a year
- Measured from
- Dec 2009to Oct 2026, 16 years 10 months
- Johnson & Johnson, Real $ (US CPI)$261.40
- $ nominal$261.40
- Oct 2026, latest
Loading the chart. Every figure is also in the table below.
| Period | $ nominal | £ nominal | Real $ (US CPI) | Real £ (UK CPI) | vs US M2 |
|---|---|---|---|---|---|
| Past year from Oct 2025 | +38.4% | +37.5% | –a (see note a) | +33.8% | +31.9% |
| 5 years from Oct 2021 | +60.5% 9.9% a year | +66.0% 10.7% a year | +32.5% 5.8% a year | +31.3% 5.6% a year | +45.5% 7.8% a year |
| Since 2020 from Dec 2019 | +79.2% 8.9% a year | +79.7% 9.0% a year | +37.5% 4.8% a year | +35.8% 4.6% a year | +17.9% 2.4% a year |
| 10 years from Oct 2016 | +125% 8.5% a year | +108% 7.6% a year | +62.7% 5.0% a year | +46.6% 3.9% a year | +26.7% 2.4% a year |
| Since 2010 from Dec 2009 | +306% 8.7% a year | +396% 10.0% a year | +162% 5.9% a year | +204% 6.8% a year | +48.0% 2.4% a year |
| Since 2000 from Dec 1999 | +461% 6.6% a year | +584% 7.4% a year | +182% 3.9% a year | +246% 4.7% a year | +11.4% 0.4% a year |
| Since Jan 1985 first month in our data | +10,626% 11.8% a year | +9,062% 11.4% a year | +3,278% 8.8% a year | +2,627% 8.2% a year | +972% 5.8% a year |
- a US CPI was not published for Oct 2025.
How these figures are worked out
Sources, inflation measures and what is left out
- Month-end closes from Yahoo Finance, Nasdaq, Jan 1985 to Oct 2026. Oct 2026 is still in progress, so its figure is the latest close rather than a month-end. Our history for Johnson & Johnson starts in Jan 1985, so longer windows are left out.
- Real figures divide by US CPI (BLS, via FRED) or UK CPI (ONS, joined to the ONS long-run RPI before Jan 1988) and are stated in Oct 2026 money. The M2 lens divides by the US M2 money supply (Federal Reserve, via FRED). Pounds convert at each month's GBP/USD rate.
- US CPI is published with a lag: Oct 2026 uses the Aug 2026 figure.
- UK CPI is published with a lag: Oct 2026 uses the Aug 2026 figure.
- US M2 is published with a lag: Oct 2026 uses the Aug 2026 figure.
- Price returns only: dividends are not included, so the total return to a holder who reinvested them was higher.
- A return of 12 months or more also shows its yearly rate. Gaps in a source are left as gaps and never filled in.
Johnson & Johnson price history, past year
Daily closes from Nasdaq. Last refreshed .
Where Johnson & Johnson stands today
52-week range
- Below the high
- 10.4%
- Above the low
- 34.2%
Johnson & Johnson sits in the middle part of its range, 34.2% above the $186.00 low from 5 Nov 2025 and 10.4% below the $278.43 high from 3 Sept 2026. About 71% of the year's daily closes were lower than today's price.
Moving averages
- 50-day$265.38 -6.0%
- 200-day$243.42 +2.5%
Price compared with each average. Bars to the right mean the price is above it.
Johnson & Johnson has slipped 6.0% below its 50-day average but is still 2.5% above the 200-day, which tells us the recent dip hasn't yet broken the longer uptrend. The 50-day line has stayed above the 200-day on every day since 24 Jun 2026, as far back as our data lets us check.
Trend score
- Trend70
- Momentum27
- RSI score38
- Drawdown79
- Uptrend
- 65 or more
- Sideways
- 36 to 64
- Downtrend
- 35 or less
Rules-based, from 277 daily prices. It describes the trend so far and does not predict the next move. How it works.
Johnson & Johnson performance and biggest moves
Returns over time
| Period | JNJ | SPY | Gap |
|---|---|---|---|
| 1 week | -2.1% | -0.1% | −2.0 pts |
| 1 month | -6.0% | +1.9% | −7.9 pts |
| 3 months | +1.0% | +3.1% | −2.1 pts |
| Year to date | +20.6% | +14.2% | +6.4 pts |
| 1 year | +30.7% | +17.4% | +13.3 pts |
Johnson & Johnson is up 30.7% over the past year on price alone, against +17.4% for the S&P 500 (through the SPY fund), so it has beaten that comparison by 13.3 percentage points. Dividends are not included, so the total return for holders would be a little higher.
Best and worst days in the past year
- Days that closed higher
- 53%
- Moves of 3% or more
- 7
The biggest one-day rise since 13 Oct 2025 came on 26 Jun 2026 (+4.0%) and the sharpest fall on 30 Jul 2026 (−3.7%). Of the 251 trading days in that period, 53% closed higher than the day before and 7 moved by 3% or more in one direction or the other.
Is Johnson & Johnson overbought, and how volatile is it?
RSI (14-day)
Soft- Sessions at 70+ (past year)
- 52
- Sessions at 30 or lower
- 3
At 35.1, Johnson & Johnson's RSI is below the halfway mark but still above 30, so sellers have had a little more of the recent action than buyers without it turning into the kind of slide we'd call oversold. It has been at 30 or lower on 3 sessions in the past year, the latest on 5 Oct 2026.
Volatility against other US shares
12th most volatile of 27- Typical daily move
- 1.5%
- Calmest in group
- BRK.B 10.8%
Johnson & Johnson's 30-day volatility is 23.8%, which works out at a move of roughly 1.5% on an ordinary day. That makes it the 12th most volatile of the 27 US shares we track, close to the group median of 23.3%. We use the same 30-day window for every asset so the ranking is like for like, though it shifts as big days drop out of the window.
Johnson & Johnson compared with similar assets
| Asset | Price | Today | 1 month | 1 year | RSI | Trend score |
|---|---|---|---|---|---|---|
| JNJJohnson & Johnson | $249.54 | +0.37% | -6.0% | +30.7% | 35 | 52 Sideways |
| LLYEli Lilly | $1,167.61 | +0.05% | +4.7% | +42.5% | 50 | 70 Uptrend |
| UNHUnitedHealth | $378.11 | +0.12% | -0.3% | +5.4% | 48 | 61 Sideways |
| PGProcter & Gamble | $152.75 | -0.20% | +5.1% | +3.6% | 64 | 76 Uptrend |
Over the past year Eli Lilly has done best in this group (+42.5%) and Procter & Gamble has been the weakest (+3.6%). Johnson & Johnson comes 2nd of 4, 11.8 percentage points behind Eli Lilly.
About Johnson & Johnson
Johnson & Johnson was founded in 1886. Since spinning off its consumer brands as Kenvue in 2023 it has concentrated on prescription medicines and medical technology.
- Ticker
- JNJ
- Type
- Stock
- Sector
- Pharmaceuticals
- Priced in
- USD
Third-party market headlines
Headlines from outside publishers, linked to their sites. We don't write or endorse them.
- TECHNOLOGY Is it OK for jobseekers or employers to use AI?
- TECHNOLOGY Chip stocks suffer worst stretch in 16 months as AI fatigue grips the market
- STOCKS The SpaceX threat could loom over AT&T’s stock for a prolonged stretch, analyst cautions
- STOCKS Six Flags’ stock slumps near 17-year low after fatal incident
- STOCKS AST SpaceMobile’s stock is feeling the heat from SpaceX’s wireless plans
- TECHNOLOGY Was Broadcom CEO bullish or bearish on AI? ‘Gamblers’ comment creates storm.
Johnson & Johnson: questions people ask
Answers are built from the same live figures shown above, so they change as the price does. Last checked 14 Oct 2026.
Has Johnson & Johnson beaten inflation since 2010?
Yes. From the December 2009 close to October 2026, Johnson & Johnson went up 306% in dollars. US consumer prices rose 55.1% over the same months, which leaves a real gain of 162%, or 5.9% a year after inflation. A UK holder counting in pounds saw up 396%, which comes to up 204% once UK CPI is taken out. These are price returns: dividends are not included, so a holder who reinvested them did better.
How has Johnson & Johnson done against money printing?
The US M2 money supply grew 174% since 2010. M2 counts the cash, current accounts and savings deposits held in the US, so it measures how much new money was created rather than how much shop prices rose. Against it, Johnson & Johnson is up 48.0%.
What is Johnson & Johnson's real return over 10 years?
Over the 10 years to October 2026, Johnson & Johnson returned 125% in dollars (8.5% a year). After US inflation that is up 62.7%, 5.0% a year. In pounds after UK inflation it is up 46.6%.
What is the Johnson & Johnson share price today?
The last price we have for Johnson & Johnson is $249.54, up 0.4% on the day, as of 23:55 BST on 13 Oct 2026. We get US prices from Nasdaq and during trading hours they can be up to 15 minutes behind, so if you are about to trade you'll want the live quote from your broker rather than ours. Over the last month the shares have moved −6.0% and over the last year +30.7%.
Is Johnson & Johnson stock overbought right now?
No, or at least not on the 14-day RSI, which reads 35.1 at the moment. We'd only start calling Johnson & Johnson overbought above 70 and it hasn't been there since 7 Jul 2026, while the last time it went the other way and dropped below 30 was 5 Oct 2026. RSI looks back over 14 sessions and asks how much of the movement was up and how much was down, so a reading in the 30s or 40s mostly tells us the past few weeks have been tilted towards sellers without getting extreme. Johnson & Johnson has been at 30 or below on 3 sessions in the past year, and a low reading can last for a while when a fall is driven by news, so we don't read it as a sign that the drop is over.
How far is Johnson & Johnson from its 52-week high?
About 10.4%, so it would need to rise 11.6% to get back there. The highest close in the past year was $278.43 on 3 Sept 2026 and the lowest was $186.00 on 5 Nov 2025, which puts today's price 69% of the way up that range. We work this out from daily closing prices rather than the intraday highs and lows an exchange reports, so our high can be a little lower than the one you'll see quoted elsewhere.
Is Johnson & Johnson above its 200-day moving average?
It is. Johnson & Johnson's last price of $249.54 is 2.5% above its 200-day average of $243.42, and the 50-day average of $265.38 is above the 200-day as well, which has been true on every day since 24 Jun 2026, as far back as our data goes. We show the 200-day line because it averages about ten months of closing prices, so a single bad week hardly moves it, and when we look at a chart it's the quickest way to see whether a share has been rising or falling over the longer run, even if it can't tell us where the price goes from here.
How volatile is Johnson & Johnson stock?
Over the past 30 days Johnson & Johnson's annualised volatility has been 23.8%. If that number feels abstract, it works out at roughly a 1.5% move on an ordinary day. It is the 12th most volatile of the 27 US shares we track and the median for the group is 23.3%, so at the moment it is about as jumpy as a typical member of the group. The biggest single-day swings of the past year were +4.0% on 26 Jun 2026 and −3.7% on 30 Jul 2026.
Important information
Capital at risk. The value of investments can fall as well as rise and you may get back less than you invest. Past performance is not a reliable indicator of future results. Educational information only, not financial advice. Read our disclaimer.
Johnson & Johnson: what the numbers say
Claude Haiku ·Johnson & Johnson closed at $248.58 today, down 5.74% with the US market open. The shares sit 10.7% below their 52-week closing high of $278.43, reached on 3 September 2026, and 33.6% above their closing low of $186.00, set on 5 November 2025. The price is above the 200-day average of $243.4 but below the 50-day average of $265.4. Over the past year the stock has still risen 30.21%.
Read the full summary Show less
The trend score is 51, labelled Sideways. Its trend reading is 70 and its momentum reading is 26, with the RSI at 34.4. Over the last 30 days the shares have fallen 6.4%, with annualised volatility of 24.5%. Peers were softer today, with Eli Lilly down 1.95%, UnitedHealth slipping 0.12% and Procter & Gamble down 0.02%.
Written by AI from this site's live data and checked figure by figure before publishing. Educational only, not financial advice.